The issued claim in the current patent covers a method of diagnosing a motor neuron disease based on sequences associated with mutations in the neuropathy target esterase (NTE) gene. If one reads the specification, descriptions of treatments based on inhibiting expression of the mutated NTE gene using techniques such as siRNA are disclosed...
Stem cell therapy for conditions such as multiple sclerosis is promising in part because of the possibility of remyelination, as well as the immune modulatory properties of the stem cells, especially mesenchymal stem cells.